ArticleCureus2024

Human Epidermal Growth Factor Receptor Type 2 (HER2)-Positive Metastatic Breast Cancer With HER2-Negative Conversion: A Case Report and Treatment With Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor for the Luminal Type.

Ryo Funakushi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.